Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Journal of Atherosclerosis and Thrombosis|May 13, 2003
Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cellsMasumi Kamiyama, Kazunori Utsunomiya, Kanta Taniguchi, et al.Geroscience|February 9, 2026
Kidney function and all-cause mortality in the oldest-old population: a three-cohort longitudinal studyHideaki Kurata, Shu Meguro, Yukiko Abe, et al.Scientific Reports|August 17, 2016
Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human PlasmaToshimi Kido, Hideaki Kurata, Kazuo Kondo, et al.Lipids in Health and Disease|December 1, 2017
ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicatorToshimi Kido, Kazuo Kondo, Hideaki Kurata, et al.Medicine|December 20, 2014
Vascular Ehlers-Danlos syndrome without the characteristic facial features: a case reportRyota Inokuchi, Hideaki Kurata, Kiyoshi Endo, et al.BMC Geriatrics|August 9, 2023
Dietary protein intake and all-cause mortality: results from The Kawasaki Aging and Wellbeing ProjectHideaki Kurata, Shu Meguro, Yukiko Abe, et al.European Journal of Pharmacology|May 22, 2007
The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic ratsAtsushi Gojo, Kazunori Utsunomiya, Kanta Taniguchi, et al.European Journal of Nutrition|September 29, 2009
Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophagesYoshimi Kishimoto, Mariko Tani, Harumi Uto-Kondo, et al.Atherosclerosis|July 19, 2008
Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) StudyNaoko Tajima, Hideaki Kurata, Noriaki Nakaya, et al.Cardiovascular Diabetology|May 30, 2008
Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failureYumi Miyashita, Rimei Nishimura, Masami Nemoto, et al.Pageof 3